The Ottawa Hospital, Division of General Internal Medicine, Ottawa, Ontario, Canada.
University of Ottawa, Faculty of Medicine, Ottawa, Ontario, Canada.
West J Emerg Med. 2022 Feb 28;23(2):166-173. doi: 10.5811/westjem.2022.1.53834.
Substance use-related visits to the emergency department (ED) have been linked to higher service delivery costs, although little is known about the specific services used. Our goal In this study was to describe the recent trends of substance use-related ED visits and assess the association between substance use and specific ED resource utilization.
We performed a retrospective, cross-sectional study using the National Hospital Ambulatory Medical Care Survey (NHAMCS) data from 2013-2018. All ED visits in the United States for patients ≥18 years of age were included. The primary exposure was having substance use included as a chief complaint or diagnosis, which we identified using the International Classification of Diseases, 9th and 10th revisions, codes. The primary outcome was the use of diagnostic services (including laboratory studies and cardiac monitoring) or imaging studies in the ED.
The study sample included 95,506 visits in the US, extrapolating to over 619 million ED visits nationwide. The total number of ED visits remained stable during the study period, but substance use-related visits increased by 45%, with these visits making up 2.93% of total ED visits in 2013 and 4.25% in 2018. This increase was primarily driven by stimulant-, sedative- (opioids and benzodiazepines), and hallucinogen-related visits. Mental health-related visits rose in parallel by 66% during the same period. Compared to non-substance use-related visits, substance use-related visits were more likely to undergo any diagnostic study (adjusted odds ratio [aOR] 1.28; 95% confidence interval (CI): 1.11-1.47; P = 0.001), toxicology screening (aOR 10.15; 95% CI: 8.84-11.66), but less likely to have imaging studies (aOR 0.62; 95% CI: 0.56-0.68; P <0.0001). In stratified analyses, substance use-related visits with concurrent mental health disorders were more likely to undergo imaging studies (aOR 1.56; 95% CI: 1.09-2.22), while findings were opposite for those without concurrent mental health disorders (aOR 0.64; 95% CI: 0.51-0.71; P for interaction <0.0001).
Substance use- and mental health-related ED visits are rising, and they are associated with increased resource utilization. Further studies are needed to provide more guidance in the approach to acute services in this vulnerable population.
与物质使用相关的急诊科(ED)就诊与更高的服务提供成本有关,尽管人们对使用的具体服务知之甚少。我们的研究目标是描述与物质使用相关的 ED 就诊的近期趋势,并评估物质使用与特定 ED 资源利用之间的关联。
我们使用 2013 年至 2018 年的国家医院门诊医疗调查(NHAMCS)数据进行了回顾性、横断面研究。纳入了美国≥18 岁患者的所有 ED 就诊。主要暴露因素是将物质使用作为主要投诉或诊断,我们使用国际疾病分类,第 9 版和第 10 版代码来识别。主要结局是在 ED 中使用诊断服务(包括实验室研究和心脏监测)或影像学研究。
研究样本包括美国的 95506 次就诊,推断全国超过 6.19 亿次 ED 就诊。研究期间,ED 就诊总数保持稳定,但与物质使用相关的就诊增加了 45%,这些就诊占 2013 年总 ED 就诊的 2.93%和 2018 年的 4.25%。这种增加主要是由兴奋剂、镇静剂(阿片类药物和苯二氮䓬类药物)和致幻剂相关就诊引起的。同期精神健康相关就诊增加了 66%。与非物质使用相关的就诊相比,物质使用相关就诊更有可能进行任何诊断研究(调整优势比[aOR]1.28;95%置信区间[CI]:1.11-1.47;P=0.001)、毒理学筛查(aOR 10.15;95%CI:8.84-11.66),但不太可能进行影像学研究(aOR 0.62;95%CI:0.56-0.68;P<0.0001)。在分层分析中,同时患有精神健康障碍的物质使用相关就诊更有可能进行影像学研究(aOR 1.56;95%CI:1.09-2.22),而同时没有精神健康障碍的就诊则相反(aOR 0.64;95%CI:0.51-0.71;P<0.0001)。
与物质使用和精神健康相关的 ED 就诊正在增加,并且与资源利用的增加有关。需要进一步研究,为这一弱势群体的急性服务方法提供更多指导。